Drug-Target Association Kinetics in Drug Discovery

被引:48
|
作者
IJzerman, Adriaan P. [1 ]
Guo, Dong [2 ]
机构
[1] Leiden Univ, LACDR, Div Drug Discovery & Safety, POB 9502, NL-2300 RA Leiden, Netherlands
[2] Xuzhou Med Univ, Jiangsu Key Lab New Drug Res & Clin Pharm, 209 Tongshan Rd, Xuzhou 221004, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
PROTEIN-COUPLED RECEPTOR; BINDING-KINETICS; RESIDENCE TIME; IN-VIVO; LIGAND-BINDING; LONG; DISSOCIATION; MECHANISM; EFFICACY; PHARMACOLOGY;
D O I
10.1016/j.tibs.2019.04.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The important role of ligand-receptor binding kinetics in drug design and discovery is increasingly recognized by the drug research community. Over the past decade, accumulating evidence has shown that optimizing the ligand's dissociation rate constant can lead to desirable duration of in vivo target occupancy and, hence, improved pharmacodynamic properties. However, the association rate constant as a pharmacological principle remains less investigated, whereas it can play an equally important role in the selection of drug candidates. This review provides a compilation and discussion of otherwise scarce and dispersed information on this topic, bringing to light the importance of drug -target association in kinetics-directed drug design and discovery.
引用
收藏
页码:861 / 871
页数:11
相关论文
共 50 条
  • [31] A multi-faceted glycan analysis for cancer biomarker/drug-target discovery
    Kuno, Atsushi
    CANCER SCIENCE, 2023, 114 : 711 - 711
  • [32] Polypharmacological Drug-target Inference for Chemogenomics
    Schneider, Petra
    Schneider, Gisbert
    MOLECULAR INFORMATICS, 2018, 37 (9-10)
  • [33] Does drug-target have a likeness?
    Xu, H.
    Fang, Y.
    Yao, L.
    Chen, Y.
    Chen, X.
    METHODS OF INFORMATION IN MEDICINE, 2007, 46 (03) : 360 - 366
  • [34] Combining Drug and Gene Similarity Measures for Drug-Target Elucidation
    Perlman, Liat
    Gottlieb, Assaf
    Atias, Nir
    Ruppin, Eytan
    Sharan, Roded
    JOURNAL OF COMPUTATIONAL BIOLOGY, 2011, 18 (02) : 133 - 145
  • [35] The importance of drug-target residence time
    Zhang, Rumin
    Monsma, Frederick
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2009, 12 (04) : 488 - 496
  • [36] DRUG-TARGET INTERACTIONS Stay tuned
    Copeland, Robert A.
    NATURE CHEMICAL BIOLOGY, 2015, 11 (07) : 451 - 452
  • [37] An Efficient Drug Design Method Based on Drug-Target Affinity
    Liu, Haoran
    Zhang, Xiaolong
    Lin, Xiaoli
    Hu, Jing
    ADVANCED INTELLIGENT COMPUTING TECHNOLOGY AND APPLICATIONS, ICIC 2023, PT III, 2023, 14088 : 764 - 775
  • [38] Mechanistic models enable the rational use of in vitro drug-target binding kinetics for better drug effects in patients
    de Witte, Wilhelmus E. A.
    Wong, Yin Cheong
    Nederpelt, Indira
    Heitman, Laura H.
    Danhof, Meindert
    van der Graaf, Piet H.
    Gilissen, Ron A. H. J.
    de Lange, Elizabeth C. M.
    EXPERT OPINION ON DRUG DISCOVERY, 2016, 11 (01) : 45 - 63
  • [39] Kinetics for Drug Discovery: an industry-driven effort to target drug residence time
    Schuetz, Doris A.
    de Witte, Wilhelmus Egbertus Arnout
    Wong, Yin Cheong
    Knasmueller, Bernhard
    Richter, Lars
    Kokh, Daria B.
    Sadiq, S. Kashif
    Bosma, Reggie
    Nederpelt, Indira
    Heitman, Laura H.
    Segala, Elena
    Amaral, Marta
    Guo, Dong
    Andres, Dorothee
    Georgi, Victoria
    Stoddart, Leigh A.
    Hill, Steve
    Cooke, Robert M.
    De Graaf, Chris
    Leurs, Rob
    Frech, Matthias
    Wade, Rebecca C.
    de Lange, Elizabeth Cunera Maria
    IJzerman, Adriaan P.
    Mueller-Fahrnow, Anke
    Ecker, Gerhard F.
    DRUG DISCOVERY TODAY, 2017, 22 (06) : 896 - 911
  • [40] How target kinetics guide drug discovery: implications in drug design and in vivo pharmacology
    Bradshaw-Pierce, Erica L.
    Hosea, Natalie A.
    Hixon, Mark S.
    DRUG METABOLISM REVIEWS, 2016, 48 : 63 - 63